Current Challenges in Vaccinology

Multi-omics approaches to disease

Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953 · see citing works

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

Breuer, K., Foroushani, A. B. K., Laird, M. R., Chen, C. C. L., Sribnaia, A., Lo, R., Winsor, G. L., Hancock, R. E. W., Brinkman, F. S. L., & Lynn, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1147 · Cited by 1,224 · see citing works

Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry

Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198 · see citing works

MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions

Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,191 · see citing works

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D. E., Pirani, A. M., Gernert, K. M., Deng, J., Marzolf, B., et al. (2008) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,123 · see citing works

Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences

Brodin, P., Jojic, V., Gao, T., Bhattacharya, S., Angel, C. J. L., Furman, D., Shen-Orr, S., Dekker, C. L., Swan, G. E., Butte, A. J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.020 · Cited by 1,065 · see citing works

Centers for Disease Control and Prevention (CDC)

García-Basteiro, A. L. (2011) · Encyclopedia of Disaster Relief · doi:10.4135/9781412994064.n25 · Cited by 1,021 · see citing works

ImmPort, toward repurposing of open access immunological assay data for translational and clinical research

Bhattacharya, S., Dunn, P. J., Thomas, C. G., Smith, B., Schaefer, H., Chen, J., Hu, Z., Zalocusky, K. A., Shankar, R., Shen-Orr, S. S., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.15 · Cited by 788 · see citing works

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

Li, S., Rouphael, N., Duraisingham, S., Romero‐Steiner, S., Presnell, S., Davis, C. W., Schmidt, D. S., Johnson, S. E., Milton, A., Rajam, G., et al. (2013) · Nature Immunology · doi:10.1038/ni.2789 · Cited by 772 · see citing works

Adaptive evolution of highly mutable loci in pathogenic bacteria

Moxon, E. R., Rainey, P. B., Nowak, M. A., & Lenski, R. E. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00005-1 · Cited by 755 · see citing works

Control of B-cell responses by Toll-like receptors

Pasare, C., & Medzhitov, R. M. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752 · see citing works

Human immune system variation

Brodin, P., & Davis, M. M. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2016.125 · Cited by 730 · see citing works

Reverse vaccinology

Rappuoli, R. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00119-3 · Cited by 725 · see citing works

Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum

Crosnier, C., Bustamante, L. Y., Scott, J. B., Bei, A. K., Theron, M., Uchikawa, M., Mboup, S., Ndir, O., Kwiatkowski, D. P., Duraisingh, M. T., et al. (2011) · Nature · doi:10.1038/nature10606 · Cited by 665 · see citing works

Vaccines: past, present and future

Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 597 · see citing works

Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans

Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572 · see citing works

TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination

Oh, J. Z., Ravindran, R., Chassaing, B., Carvalho, F. A., Maddur, M. S., Bower, M., Hakimpour, P., Gill, K. P., Nakaya, H. I., Yarovinsky, F., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.009 · Cited by 541 · see citing works

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

Mueller, A., Labaied, M., Kappe, S., & Matuschewski, K. (2005) · Nature · doi:10.1038/nature03188 · Cited by 540 · see citing works

Regulatory R-loops as facilitators of gene expression and genome stability

Niehrs, C., & Luke, B. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0206-3 · Cited by 525 · see citing works

A large peptidome dataset improves HLA class I epitope prediction across most of the human population

Sarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 505 · see citing works

Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

de Figueiredo, P., Ficht, T., Rice-Ficht, A., Rossetti, C., & Adams, L. G. (2015) · American Journal of Pathology · doi:10.1016/j.ajpath.2015.03.003 · Cited by 459 · see citing works

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

Khurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., Giudice, G. D., Rappuoli, R., & Golding, H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002336 · Cited by 357 · see citing works

Ten great public health achievements--United States, 1900-1999.

(1999) · PubMed · Cited by 342 · see citing works

Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel

Halsell, J. S. (2003) · JAMA · doi:10.1001/jama.289.24.3283 · Cited by 333 · see citing works

A proof of concept for structure-based vaccine design targeting RSV in humans

Crank, M. C., Ruckwardt, T. J., Chen, M., Morabito, K. M., Phung, E., Costner, P. J., Holman, L. A., Hickman, S. P., Berkowitz, N. M., Gordon, I. J., et al. (2019) · Science · doi:10.1126/science.aav9033 · Cited by 333 · see citing works

Genetic Variants Regulating Immune Cell Levels in Health and Disease

Orrù, V., Steri, M., Sole, G., Sidore, C., Virdis, F., Dei, M., Lai, S., Żołędziewska, M., Busonero, F., Mulas, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.041 · Cited by 330 · see citing works

Long walk to genomics: History and current approaches to genome sequencing and assembly

Giani, A. M., Gallo, G. R., Gianfranceschi, L., & Formenti, G. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.11.002 · Cited by 306 · see citing works

Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season

Rolfes, M. A. R., Flannery, B. L., Chung, J. R., O’Halloran, A. C., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 298 · see citing works

Systems analysis of protective immune responses to RTS,S malaria vaccination in humans

Kazmin, D. A., Nakaya, H. I., Lee, E. K., Johnson, M. J., der Most, R. G. V., van den Berg, R. A., Ballou, W. R., Jongert, E., Wille-Reece, U., Ockenhouse, C. F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621489114 · Cited by 293 · see citing works

Chromatin replication and epigenetic cell memory

Stewart-Morgan, K. R., Petryk, N., & Groth, A. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0487-y · Cited by 281 · see citing works

Metabolic Phenotypes of Response to Vaccination in Humans

Li, S., Sullivan, N., Rouphael, N., Yu, T., Banton, S., Maddur, M. S., McCausland, M. M., Chiu, C., Canniff, J. D., Dubey, S. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.026 · Cited by 277 · see citing works

Defining B cell immunodominance to viruses

Angeletti, D., Gibbs, J. S., Angel, M., Košík, I., Hickman, H. D., Frank, G. M., Das, S. R., Wheatley, A. K., Prabhakaran, M. S., Leggat, D. J., et al. (2017) · Nature Immunology · doi:10.1038/ni.3680 · Cited by 257 · see citing works

Reticulocyte-binding protein homologue 5 – An essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum

Baum, J., Chen, L., Healer, J., Lopaticki, S., Boyle, M. J., Triglia, T., Ehlgen, F., Ralph, S. A., Beeson, J. G., & Cowman, A. F. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.10.006 · Cited by 255 · see citing works

Structure-Based Vaccine Antigen Design

Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234 · see citing works

The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment

Brockmeier, E. K., Hodges, G., Hutchinson, T. H., Butler, E., Hecker, M., Tollefsen, K. E., García‐Reyero, N., Kille, P., Becker, D., Chipman, K., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx097 · Cited by 232 · see citing works

Genetic regulation of immune responses to vaccines in early life

Newport, M. J., Goetghebuer, T., Weiss, H. A., The MRC Gambia Twin Study Group, Whittle, H., Siegrist, C., & Marchant, A. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364051 · Cited by 208 · see citing works

Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age

Halstead, S. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.089 · Cited by 205 · see citing works

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

Grifantini, R., Bartolini, E., Muzzi, A., Draghi, M., Frigimelica, E., Berger, J. P., Ratti, G., Petracca, R., Galli, G., Agnusdei, M., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt728 · Cited by 204 · see citing works

Immune monitoring using mass cytometry and related high-dimensional imaging approaches

Hartmann, F. J., & Bendall, S. C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0338-z · Cited by 203 · see citing works

Personalized vaccinology: A review

Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.062 · Cited by 196 · see citing works

Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging

Bocker, M., Hellwig, I., Breiling, A., Eckstein, V., Ho, A. D., & Lyko, F. (2011) · Blood · doi:10.1182/blood-2011-01-331926 · Cited by 195 · see citing works

Heterogeneity in Vaccine Immune Response: The Role of Immunogenetics and the Emerging Field of Vaccinomics

Poland, G. A., Ovsyannikova, I. G., Jacobson, R. M., & Smith, D. I. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100415 · Cited by 193 · see citing works

Computational strategies for dissecting the high-dimensional complexity of adaptive immune repertoires

Miho, E., Yermanos, A., Weber, C. R., Berger, C. T., Reddy, S. T., & Greiff, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00224 · Cited by 189 · see citing works

Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins

Höhler, T., Reuss, E., Evers, N., Dietrich, E., Rittner, C. K., Freitag, C. M., Vollmar, J., Schneider, P. M., & Fimmers, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11083-x · Cited by 186 · see citing works

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Heijne, W. H. M., Kienhuis, A. S., van Ommen, B., Stierum, R. H., & Groten, J. P. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.5.767 · Cited by 184 · see citing works

The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance

Lee, L. A., Franzel, L., Atwell, J. E., Datta, S., Friberg, I. K., Goldie, S. J., Reef, S. E., Schwalbe, N., Simons, E. A., Strebel, P. M., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.11.035 · Cited by 182 · see citing works

Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies

Baharlou, H., Canete, N. P., Cunningham, A. L., Harman, A. N., & Patrick, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02657 · Cited by 176 · see citing works

Vaccination against bubonic and pneumonic plague

Titball, R. W., & Williamson, E. D. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00163-3 · Cited by 173 · see citing works

Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem

Havenar‐Daughton, C., Lee, J. H., & Crotty, S. (2017) · Immunological Reviews · doi:10.1111/imr.12512 · Cited by 170 · see citing works

A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination

Engler, R. J. M., Nelson, M. R., Collins Jr., L. C., Spooner, C., Hemann, B. A., Gibbs, B. T., Atwood, J. E., Howard, R. S., Chang, A. S., Cruser, D. L., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118283 · Cited by 169 · see citing works

Twin studies of immunogenicity — determining the genetic contribution to vaccine failure

Tan, P., Jacobson, R. M., Poland, G. A., Jacobsen, S. J., & Pankratz, V. S. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00468-0 · Cited by 161 · see citing works

Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood

Nakaya, H. I., Clutterbuck, E., Kazmin, D. A., Wang, L., Cortese, M., Bosinger, S. E., Patel, N. B., Zak, D. E., Aderem, A. A., Dong, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519690113 · Cited by 158 · see citing works

Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States

Ozawa, S., Portnoy, A., Getaneh, H., Clark, S. E., Knoll, M. D., Bishai, D. M., Yang, H. K., & Patwardhan, P. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0462 · Cited by 154 · see citing works

Common variants associated with general and MMR vaccine–related febrile seizures

Feenstra, B., Pasternak, B., Geller, F., Carstensen, L., Wang, T., Huang, F., Eitson, J. L., Hollegaard, M. V., Svanström, H., Vestergaard, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3129 · Cited by 152 · see citing works

Relationship Between Virulence and Immunity as Revealed in Recent Studies of the Fl Capsule of Yersinia pestis

Friedlander, A. M., Welkos, S. L., Worsham, P. L., Andrews, G. P., Heath, D. G., Anderson, G. W., Pitt, M. L. M., Estep, J. E., & Davis, K. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.supplement_2.s178 · Cited by 148 · see citing works

Microbiology by numbers

(2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2644 · Cited by 147 · see citing works

Neutralization of Plasmodium falciparum Merozoites by Antibodies against PfRH5

Douglas, A. D., Williams, A. R., Knuepfer, E., Illingworth, J. J., Furze, J. M., Crosnier, C., Choudhary, P., Bustamante, L. Y., Zakutansky, S. E., Awuah, D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302045 · Cited by 145 · see citing works

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete

Hanage, W. P., Finkelstein, J. A., Huang, S. S., Pelton, S. I., Stevenson, A. E., KLEINMAN, K. P., Hinrichsen, V. L., & Fraser, C. (2010) · Epidemics · doi:10.1016/j.epidem.2010.03.005 · Cited by 144 · see citing works

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

Frey, S. E., Reyes, M. R. A.-D. L., Reynales, H., Bermal, N., Nicolay, U., Narasimhan, V., Forleo‐Neto, E., & Arora, A. K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.013 · Cited by 143 · see citing works

Neisseria meningitidis: pathogenesis and immunity

Pizza, M., & Rappuoli, R. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.006 · Cited by 143 · see citing works

Progress Toward Regional Measles Elimination — Worldwide, 2000–2014

Perry, R. T., Murray, J., Gacic-Dobo, M., Dabbagh, A. J., Mulders, M. N., Strebel, P. M., Okwo‐Bele, J., Rota, P. A., & Goodson, J. L. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a4 · Cited by 143 · see citing works

Response to hepatitis B vaccine: multiple HLA genes are involved

Desombere, I., Willems, A., & Leroux‐Roels, G. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03001.x · Cited by 141 · see citing works

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program

Poland, G. A., Grabenstein, J. D., & NEFF, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.012 · Cited by 133 · see citing works

New approaches to understanding the immune response to vaccination and infection

Furman, D., & Davis, M. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.117 · Cited by 130 · see citing works

Integrative genomic analysis of the human immune response to influenza vaccination

Franco, L. M., Bucasas, K. L., Wells, J. M., Niño, D., Wang, X., Zapata, G. E., Arden, N. H., Renwick, A., Yu, P., Quarles, J. M., et al. (2013) · eLife · doi:10.7554/elife.00299 · Cited by 128 · see citing works

The application of virus-like particles as vaccines and biological vehicles

Yan, D., Wei, Y., Guo, H., & Sun, S. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7000-8 · Cited by 127 · see citing works

Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach

Lambert, N. D., Ovsyannikova, I. G., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.61 · Cited by 127 · see citing works

Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift

Altman, M. O., Angeletti, D., & Yewdell, J. W. (2018) · Viral Immunology · doi:10.1089/vim.2017.0129 · Cited by 127 · see citing works

Systems vaccinology: Enabling rational vaccine design with systems biological approaches

Hagan, T., Nakaya, H. I., Subramaniam, S., & Pulendran, B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.072 · Cited by 125 · see citing works

Heterogeneity and longevity of antibody memory to viruses and vaccines

Antia, A., Ahmed, H., Handel, A., Carlson, N. E., Amanna, I. J., Antia, R., & Slifka, M. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006601 · Cited by 123 · see citing works

Novel approaches for the design, delivery and administration of vaccine technologies

Wallis, J., Shenton, D. P., & Carlisle, R. C. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13287 · Cited by 123 · see citing works

Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century

Poland, G. A., Kennedy, R. B., McKinney, B. A., Ovsyannikova, I. G., Lambert, N. D., Jacobson, R. M., & Oberg, A. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.007 · Cited by 121 · see citing works

Associations between Human Leukocyte Antigens and Nonresponsiveness to Influenza Vaccine

Gelder, C. M., Lambkin‐Williams, R., Hart, K. W., Fleming, D., Williams, O. M., Bunce, M., Welsh, K. I., Marshall, S. E., & OXFORD, J. S. (2002) · The Journal of Infectious Diseases · doi:10.1086/338014 · Cited by 110 · see citing works

Vaccinomics and Personalized Vaccinology: Is Science Leading Us Toward a New Path of Directed Vaccine Development and Discovery?

Poland, G. A., Kennedy, R. B., & Ovsyannikova, I. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002344 · Cited by 109 · see citing works

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region

Png, E., Thalamuthu, A., Ong, R. T., Snippe, H., Boland, G. J., & Seielstad, M. T. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr302 · Cited by 109 · see citing works

Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens

Zost, S. J., Wu, N. C., Hensley, S. E., & Wilson, I. A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy696 · Cited by 106 · see citing works

Data use under the NIH GWAS Data Sharing Policy and future directions

Committees, T. N. I. O. H. G. D. S. G. (2014) · Nature Genetics · doi:10.1038/ng.3062 · Cited by 100 · see citing works

One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen

Campeotto, I., Goldenzweig, A., Davey, J., Barfod, L. K., Marshall, J. M., Silk, S. E., Wright, K. E., Draper, S. J., Higgins, M. K., & Fleishman, S. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616903114 · Cited by 99 · see citing works

Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes

Ovsyannikova, I. G., Dhiman, N., Haralambieva, I. H., Vierkant, R. A., O’Byrne, M. M., Jacobson, R. M., & Poland, G. A. (2009) · Human Genetics · doi:10.1007/s00439-009-0763-1 · Cited by 96 · see citing works

Vaccinomics and a New Paradigm for the Development of Preventive Vaccines Against Viral Infections

Poland, G. A., Ovsyannikova, I. G., Kennedy, R. B., Haralambieva, I. H., & Jacobson, R. M. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0032 · Cited by 95 · see citing works

Pharmaceutical Approval Update.

Choy, M. (2016) · PubMed · Cited by 94 · see citing works

Sequential Waves of Gene Expression in Patients with Clinically Defined Dengue Illnesses Reveal Subtle Disease Phases and Predict Disease Severity

Sun, P., García, J., Comach, G., Vahey, M., Wang, Z., Forshey, B. M., Morrison, A. C., Sierra, G., Bazan, I. S., Rocha, C. A., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002298 · Cited by 92 · see citing works

Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage

Angeletti, D., & Yewdell, J. W. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.008 · Cited by 92 · see citing works

LncRNA Functions as a New Emerging Epigenetic Factor in Determining the Fate of Stem Cells

Chen, J., Wang, Y., Wang, C., Hu, J., & Li, W. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00277 · Cited by 92 · see citing works

Human Leukocyte Antigen Haplotypes in the Genetic Control of Immune Response to Measles‐Mumps‐Rubella Vaccine

Ovsyannikova, I. G., Pankratz, V. S., Vierkant, R. A., Jacobson, R. M., & Poland, G. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/500144 · Cited by 89 · see citing works

Synthetic biology for bioengineering virus‐like particle vaccines

Charlton, H. K., Vidigal, J., Carrondo, M. J. T., Middelberg, A. P. J., Roldão, A., & Lua, L. H. L. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26890 · Cited by 88 · see citing works

Metabolomics

Manchester, M., & Anand, A. (2017) · Advances in virus research · doi:10.1016/bs.aivir.2017.02.001 · Cited by 87 · see citing works

Genome-wide association study of antibody response to smallpox vaccine

Ovsyannikova, I. G., Kennedy, R. B., O’Byrne, M. M., Jacobson, R. M., Pankratz, V. S., & Poland, G. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.055 · Cited by 82 · see citing works

A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations

Pan, L., Zhang, L., Zhang, W., Wu, X., Li, Y., Yan, B., Zhu, X., Liu, X., Yang, C., Xu, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt586 · Cited by 80 · see citing works

Plague vaccine: recent progress and prospects

Sun, W., & Singh, A. K. (2019) · npj Vaccines · doi:10.1038/s41541-019-0105-9 · Cited by 80 · see citing works

Systems vaccinology and big data in the vaccine development chain

Raeven, R. H. M., van Riet, E., Meiring, H. D., Metz, B., & Kersten, G. F. A. (2018) · Immunology · doi:10.1111/imm.13012 · Cited by 77 · see citing works

Structural Vaccinology for Viral Vaccine Design

Anasir, M. I., & Poh, C. L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00738 · Cited by 74 · see citing works

Adversomics: The Emerging Field of Vaccine Adverse Event Immunogenetics

Poland, G. A., Ovsyannikova, I. G., & Jacobson, R. M. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a6a511 · Cited by 73 · see citing works

Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches

Mozzi, A., Pontremoli, C., & Sironi, M. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.09.028 · Cited by 73 · see citing works

Variability in Humoral Immunity to Measles Vaccine: New Developments

Haralambieva, I. H., Kennedy, R. B., Ovsyannikova, I. G., Whitaker, J. A., & Poland, G. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.10.005 · Cited by 72 · see citing works

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

Jin, J., Tarrant, R. D. R., Bolam, E. J., Angell‐Manning, P., Søgaard, M., Pattinson, D. J., Dulal, P., Silk, S. E., Marshall, J. M., Dabbs, R. A., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0071-7 · Cited by 72 · see citing works

Adversomics: a new paradigm for vaccine safety and design

Whitaker, J. A., Ovsyannikova, I. G., & Poland, G. A. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1038249 · Cited by 71 · see citing works

Long non-coding RNA regulation of gene expression during differentiation

Lopez-Pajares, V. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1809-6 · Cited by 71 · see citing works

HLA supertypes and immune responses to measles–mumps–rubella viral vaccine: Findings and implications for vaccine design

Ovsyannikova, I. G., Jacobson, R. M., Vierkant, R. A., Pankratz, V. S., & Poland, G. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.020 · Cited by 70 · see citing works

A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus

Liang, X., Sun, L., Teng, Y., Pan, Y., Wang, D., Hu, X., Fu, Z., He, Q., & Cao, G. (2016) · Scientific Reports · doi:10.1038/srep19176 · Cited by 69 · see citing works

Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is (“Isolate–Inactivate–Inject”) Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview

Bragazzi, N. L., Gianfredi, V., Villarini, M., Rosselli, R., Nasr, A., Hussein, A., Martini, M., & Behzadifar, M. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00062 · Cited by 67 · see citing works

Six Genes Are Preferentially Transcribed by the Circulating and Sequestered Forms of<i>Plasmodium falciparum</i>Parasites That Infect Pregnant Women

Francis, S. E., Malkov, V. A., Oleinikov, A. V., Rossnagle, E., Wendler, J. P., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2007) · Infection and Immunity · doi:10.1128/iai.00635-07 · Cited by 65 · see citing works

The Association of CD46, SLAM and CD209 Cellular Receptor Gene SNPs with Variations in Measles Vaccine-Induced Immune Responses: A Replication Study and Examination of Novel Polymorphisms

Ovsyannikova, I. G., Haralambieva, I. H., Vierkant, R. A., O’Byrne, M. M., Jacobson, R. M., & Poland, G. A. (2011) · Human Heredity · doi:10.1159/000331585 · Cited by 63 · see citing works

Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope

Pierce, B. G., Boucher, E. N., Piepenbrink, K. H., Ejemel, M., Rapp, C. A., Thomas, W. D., Sundberg, E. J., Weng, Z., & Wang, Y. (2017) · Journal of Virology · doi:10.1128/jvi.01032-17 · Cited by 63 · see citing works

Polymorphisms in the Vitamin A Receptor and Innate Immunity Genes Influence the Antibody Response to Rubella Vaccination

Ovsyannikova, I. G., Haralambieva, I. H., Dhiman, N., O’Byrne, M. M., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/649588 · Cited by 62 · see citing works

Impact of host genetic polymorphisms on vaccine induced antibody response

Linnik, J., & Egli, A. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1119345 · Cited by 62 · see citing works

Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine

Haralambieva, I. H., Ovsyannikova, I. G., Kennedy, R. B., Larrabee, B. R., Zimmermann, M. T., Grill, D. E., Schaid, D. J., & Poland, G. A. (2017) · Human Genetics · doi:10.1007/s00439-017-1768-9 · Cited by 62 · see citing works

Differential durability of immune responses to measles and mumps following MMR vaccination

Kennedy, R. B., Ovsyannikova, I. G., Thomas, A., Larrabee, B. R., Rubin, S. A., & Poland, G. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.030 · Cited by 62 · see citing works

Polymorphisms in HLA-DPB1 Are Associated With Differences in Rubella Virus-Specific Humoral Immunity After Vaccination

Lambert, N. D., Haralambieva, I. H., Kennedy, R. B., Ovsyannikova, I. G., Pankratz, V. S., & Poland, G. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu553 · Cited by 61 · see citing works

Beyond Metabolism: The Complex Interplay Between Dietary Phytoestrogens, Gut Bacteria, and Cells of Nervous and Immune Systems

Cady, N. M., Peterson, S. R., Freedman, S. N., & Mangalam, A. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00150 · Cited by 60 · see citing works

The Immunogenetics of Smallpox Vaccination

Stanley, S. L., Frey, S. E., Taillon‐Miller, P., Guo, J., Miller, R. D., Koboldt, D. C., Elashoff, M. R., Christensen, R. G., Saccone, N. L., & Belshe, R. B. (2007) · The Journal of Infectious Diseases · doi:10.1086/518794 · Cited by 58 · see citing works

Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Zou, Z., Huang, K. L., Wei, Y., Chen, H., Liu, Z., & Jin, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01554-1 · Cited by 58 · see citing works

Naming HLA diversity: A review of HLA nomenclature

Hurley, C. K. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.03.005 · Cited by 58 · see citing works

Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations

Yücesoy, B., Talzhanov, Y. A., Johnson, V. J., Wilson, N. W., Biagini, R. E., Wang, W., Frye, B. L., Weissman, D. N., Germolec, D. R., Luster, M. I., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.026 · Cited by 57 · see citing works

Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults

Fiebelkorn, A. P., Coleman, L. A., Belongia, E. A., Freeman, S. K., York, D., Bi, D., Kulkarni, A., Audet, S. A., Mercader, S., McGrew, M., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv555 · Cited by 57 · see citing works

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial

van den Berg, R. A., Coccia, M., Ballou, W. R., Kester, K. E., Ockenhouse, C. F., Vekemans, J., Jongert, E., Didierlaurent, A. M., & der Most, R. G. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00557 · Cited by 55 · see citing works

Systems analysis of human vaccine adjuvants

Harandi, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.08.001 · Cited by 54 · see citing works

Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay?

Lapa, D., Garbuglia, A. R., Capobianchi, M. R., & Porto, P. D. (2019) · Cells · doi:10.3390/cells8040305 · Cited by 54 · see citing works

Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines

Lewis, D. J., & Lythgoe, M. P. (2015) · Journal of Immunology Research · doi:10.1155/2015/909406 · Cited by 53 · see citing works

Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development

Ovsyannikova, I. G., & Poland, G. A. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9281-x · Cited by 53 · see citing works

Epitope specific antibodies and T cell receptors in the immune epitope database

Mahajan, S., Vita, R., Shackelford, D., Lane, J., Schulten, V., Zarebski, L., Jespersen, M. C., Marcatili, P., Nielsen, M., Sette, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02688 · Cited by 53 · see citing works

Pharmacology, Vaccinomics, and the Second Golden Age of Vaccinology

Poland, G. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100379 · Cited by 52 · see citing works

Vaccine safety–vaccine benefits:science and the public's perception

Wilson, C. B., & Marcuse, E. K. (2001) · Nature reviews. Immunology · doi:10.1038/35100585 · Cited by 51 · see citing works

Analysis of the Human Kinome and Phosphatome Reveals Diseased Signaling Networks Induced by Overexpression

Lun, X., Szklarczyk, D., Gábor, A., Dobberstein, N., Zanotelli, V. R., Sáez-Rodríguez, J., von Mering, C., & Bodenmiller, B. (2018) · Molecular Cell · doi:10.1016/j.molcel.2019.04.021 · Cited by 51 · see citing works

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

Scheifele, D. W., McNeil, S., Ward, B. J., Dionne, M., Cooper, C., Coleman, B. L., Loeb, M. B., Rubinstein, E., McElhaney, J. E., Hatchette, T. F., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25580 · Cited by 50 · see citing works

A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B)

(2018) · JAMA · doi:10.1001/jama.2018.1097 · Cited by 50 · see citing works

The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development

Kennedy, R. B., & Poland, G. A. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0012 · Cited by 48 · see citing works

Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients

Kennedy, R. B., Ovsyannikova, I. G., Haralambieva, I. H., Lambert, N. D., Pankratz, V. S., & Poland, G. A. (2014) · Immunogenetics · doi:10.1007/s00251-014-0776-3 · Cited by 48 · see citing works

SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine

Dhiman, N., Haralambieva, I. H., Kennedy, R. B., Vierkant, R. A., O’Byrne, M. M., Ovsyannikova, I. G., Jacobson, R. M., & Poland, G. A. (2010) · Immunogenetics · doi:10.1007/s00251-010-0423-6 · Cited by 47 · see citing works

Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine

McDermott, A. B., Cohen, S. B., Zuckerman, J. N., & Madrigal, J. A. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00203-5 · Cited by 47 · see citing works

2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine

Haralambieva, I. H., Dhiman, N., Ovsyannikova, I. G., Vierkant, R. A., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.01.004 · Cited by 47 · see citing works

Consistency of HLA associations between two independent measles vaccine cohorts: A replication study

Ovsyannikova, I. G., Pankratz, V. S., Vierkant, R. A., Jacobson, R. M., & Poland, G. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.038 · Cited by 47 · see citing works

Replication of rubella vaccine population genetic studies: Validation of HLA genotype and humoral response associations

Ovsyannikova, I. G., Jacobson, R. M., Vierkant, R. A., O’Byrne, M. M., & Poland, G. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.109 · Cited by 47 · see citing works

Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development

Johnson, K. L., Ovsyannikova, I. G., Mason, C. J., Bergen, H. R., & Poland, G. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.126 · Cited by 46 · see citing works

Cytokine Expression Patterns Associated with Systemic Adverse Events following Smallpox Immunization

McKinney, B. A., Reif, D. M., Rock, M. T., Edwards, K. M., Kingsmore, S. F., Moore, J. H., & Crowe, J. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/505503 · Cited by 46 · see citing works

Monitoring the Safety of a Smallpox Vaccination Program in the United States: Report of the Joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board

Neff, J. M., Modlin, J. F., Birkhead, G. S., Poland, G. A., Robertson, R. M., Sepkowitz, K. A., Yancy, C. W., Gardner, P., Gray, G. C., Maurer, T. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/524749 · Cited by 45 · see citing works

Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine

Ovsyannikova, I. G., Haralambieva, I. H., Vierkant, R. A., O’Byrne, M. M., Jacobson, R. M., & Poland, G. A. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834df186 · Cited by 44 · see citing works

Advances in In-silico B-cell Epitope Prediction

Sun, P., Guo, S., Sun, J., Tan, L., Lu, C. F., & Ma, Z. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666181130111827 · Cited by 43 · see citing works

Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment

Pankratz, V. S., Vierkant, R. A., O’Byrne, M. M., Ovsyannikova, I. G., & Poland, G. A. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-48 · Cited by 42 · see citing works

New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery

Dyet, K. H., DEVOY, A., McDowell, R., & Martin, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.050 · Cited by 42 · see citing works

IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT

Chen, R., Fulton, K. M., Twine, S. M., & Li, J. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21616 · Cited by 42 · see citing works

Mass Spectrometry and Peptide-based Vaccine Development

Ovsyannikova, I. G., Johnson, K. L., Bergen, H. R., & Poland, G. A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100389 · Cited by 41 · see citing works

Variable Processing and Cross-presentation of HIV by Dendritic Cells and Macrophages Shapes CTL Immunodominance and Immune Escape

Dinter, J., Duong, E., Lai, N. Y., Berberich, M. J., Kourjian, G., Bracho-Sanchez, E., Chu, D. T., Su, H., Zhang, S. C., & Gall, S. L. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004725 · Cited by 39 · see citing works

Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities

Minervini, C. F., Cumbo, C., Orsini, P., Anelli, L., Zagaria, A., Specchia, G., & Albano, F. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00076 · Cited by 39 · see citing works

Characterization of Rift Valley Fever Virus MP-12 Strain Encoding NSs of Punta Toro Virus or Sandfly Fever Sicilian Virus

Lihoradova, O. A., Indran, S. V., Kalveram, B., Lokugamage, N., Head, J. A., Gong, B., Tigabu, B., Juelich, T. L., Freiberg, A. N., & Ikegami, T. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002181 · Cited by 38 · see citing works

Therapeutics of Ebola Hemorrhagic Fever: Whole-Genome Transcriptional Analysis of Successful Disease Mitigation

Yen, J. Y., Garamszegi, S., Geisbert, J. B., Rubins, K., Geisbert, T. W., Honko, A. N., Xia, Y., Connor, J. H., & Hensley, L. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir345 · Cited by 38 · see citing works

Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion

Cifuente, J. O., & Moratorio, G. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00283 · Cited by 38 · see citing works

Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization

O’Connor, D., Png, E., Khor, C. C., Snape, M. D., Hill, A. V. S., van der Klis, F. R. M., Hoggart, C. J., Levin, M., Hibberd, M. L., & Pollard, A. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.053 · Cited by 37 · see citing works

Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes

Kennedy, R. B., Ovsyannikova, I. G., Haralambieva, I. H., O’Byrne, M. M., Jacobson, R. M., Pankratz, V. S., & Poland, G. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.025 · Cited by 35 · see citing works

Understanding the immunology of the Zostavax shingles vaccine

Sullivan, N., Eberhardt, C. S., Wieland, A., Vora, K. A., Pulendran, B., & Ahmed, R. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.005 · Cited by 35 · see citing works

Application and utility of mass cytometry in vaccine development

Reeves, P. M., Sluder, A. E., Paul, S. R., Scholzen, A., Kashiwagi, S., & Poznansky, M. C. (2017) · The FASEB Journal · doi:10.1096/fj.201700325r · Cited by 34 · see citing works

Prospects for safe and effective vaccines against prion diseases

Mabbott, N. A. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.965691 · Cited by 33 · see citing works

A Role for Genetics in the Immune Response to the Varicella Vaccine

Klein, N. P., FIREMAN, B. H., Enright, A. M., Ray, P., BLACK, S. B., & Dekker, C. L. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000257454.74513.07 · Cited by 32 · see citing works

Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination

Haralambieva, I. H., Kennedy, R. B., Simon, W. L., Goergen, K. M., Grill, D. E., Ovsyannikova, I. G., & Poland, G. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191812 · Cited by 32 · see citing works

Regulation of immune system development and function by Cbl‐mediated ubiquitination

Li, X., Gong, L., & Gu, H. (2019) · Immunological Reviews · doi:10.1111/imr.12789 · Cited by 32 · see citing works

Expression profile of interferon stimulated genes in central nervous system of mice infected with dengue virus Type-1

Bordignon, J., Probst, C., Mosimann, A. L. P., Pavoni, D. P., Stella, V., Buck, G. A., Satproedprai, N., Fawcett, P., Zanata, S. M., de Noronha, L., et al. (2008) · Virology · doi:10.1016/j.virol.2008.04.033 · Cited by 31 · see citing works

Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination

Kennedy, R. B., Ovsyannikova, I. G., Haralambieva, I. H., Lambert, N. D., Pankratz, V. S., & Poland, G. A. (2014) · Human Genetics · doi:10.1007/s00439-014-1471-z · Cited by 30 · see citing works

Human Leukocyte Antigens and Cellular Immune Responses to Anthrax Vaccine Adsorbed

Ovsyannikova, I. G., Pankratz, V. S., Vierkant, R. A., Pajewski, N. M., Quinn, C. P., Kaslow, R. A., Jacobson, R. M., & Poland, G. A. (2013) · Infection and Immunity · doi:10.1128/iai.00269-13 · Cited by 30 · see citing works

The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity

Weinberg, A., Pang, L., Johnson, M. J., Caldas, Y. A., Cho, A., Tovar-Salazar, A., Canniff, J. D., Schmader, K. E., Popmihajlov, Z., & Levin, M. J. (2019) · Journal of Virology · doi:10.1128/jvi.00305-19 · Cited by 30 · see citing works

HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study

Ovsyannikova, I. G., Pankratz, V. S., Salk, H. M., Kennedy, R. B., & Poland, G. A. (2014) · Human Genetics · doi:10.1007/s00439-014-1449-x · Cited by 29 · see citing works

Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model

Dunachie, S. J., Berthoud, T. K., Hill, A. V. S., & Fletcher, H. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.087 · Cited by 28 · see citing works

The Population Biology of Neisseria meningitidis : Implications for Meningococcal Disease, Epidemiology and Control

Maiden, M. C. J., & Caugant, D. A. (2006) · doi:10.1002/3527608508.ch2 · Cited by 28 · see citing works

Identification of Class II HLA-DRB1*03-Bound Measles Virus Peptides by 2D-Liquid Chromatography Tandem Mass Spectrometry

Johnson, K. L., Ovsyannikova, I. G., Poland, G. A., & Muddiman, D. C. (2005) · Journal of Proteome Research · doi:10.1021/pr0501416 · Cited by 27 · see citing works

Structure-based immunogen design — leading the way to the new age of precision vaccines

Sesterhenn, F., Bonet, J., & Correia, B. E. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.06.002 · Cited by 27 · see citing works

Immunophenotyping by Mass Cytometry

Behbehani, G. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9650-6_2 · Cited by 27 · see citing works

Revealing factors determining immunodominant responses against dominant epitopes

Ritmahan, W., Keşmir, C., & Vroomans, R. M. A. (2019) · Immunogenetics · doi:10.1007/s00251-019-01134-9 · Cited by 27 · see citing works

A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed

Pajewski, N. M., Shrestha, S., Quinn, C. P., Parker, S., Wiener, H. W., Aı̈ssani, B., McKinney, B. A., Poland, G. A., Edberg, J. C., Kimberly, R. P., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.032 · Cited by 26 · see citing works

Genetic effects have a dominant role on poor responses to infant vaccination to hepatitis B virus

Yan, K., Cai, W., Cao, F., Sun, H., Chen, S., Xu, R., Wei, X. P., Shi, X., & Yan, W. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.18 · Cited by 26 · see citing works

Seroprevalence and durability of rubella virus antibodies in a highly immunized population

Crooke, S. N., Haralambieva, I. H., Grill, D. E., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.049 · Cited by 26 · see citing works

Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses

Natrajan, M. S., Rouphael, N., Lai, L., Kazmin, D. A., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., et al. (2019) · Vaccines · doi:10.3390/vaccines8010004 · Cited by 25 · see citing works

Differential 3D chromatin organization and gene activity in genomic imprinting.

Noordermeer, D., & Feil, R. (2020) · Current Opinion in Genetics and Development · doi:10.1016/j.gde.2020.03.004 · Cited by 25 · see citing works

Lessons learned in the analysis of high-dimensional data in vaccinomics

Oberg, A. L., McKinney, B. A., Schaid, D. J., Pankratz, V. S., Kennedy, R. B., & Poland, G. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.088 · Cited by 24 · see citing works

HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine

Ovsyannikova, I. G., Vierkant, R. A., Pankratz, V. S., O’Byrne, M. M., Jacobson, R. M., & Poland, G. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.080 · Cited by 23 · see citing works

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare EffectiveNeisseria meningitidisVaccines

Gasparini, R., Panatto, D., Bragazzi, N. L., Lai, P. L., Bechini, A., Levi, M., Durando, P., & Amicizia, D. (2015) · Journal of Immunology Research · doi:10.1155/2015/189153 · Cited by 22 · see citing works

Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients

Grzegorzewska, A. E., Jodłowska, E., Mostowska, A., Sowińska, A., & Jagodziński, P. P. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.962521 · Cited by 22 · see citing works

Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge

Zhang, H., Tang, X., Zhu, C., Song, Y., Yin, J., Xu, J., Ertl, H. C. J., & Zhou, D. (2015) · Gene Therapy · doi:10.1038/gt.2015.31 · Cited by 22 · see citing works

Studying the Human Immunome: The Complexity of Comprehensive Leukocyte Immunophenotyping

Biancotto, A., & McCoy, J. P. (2013) · Current topics in microbiology and immunology · doi:10.1007/82_2013_336 · Cited by 21 · see citing works

HLA genotypes and rubella vaccine immune response: Additional evidence

Ovsyannikova, I. G., Pankratz, V. S., Larrabee, B. R., Jacobson, R. M., & Poland, G. A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.091 · Cited by 21 · see citing works

Gene signatures associated with adaptive humoral immunity following seasonal influenza A/H1N1 vaccination

Ovsyannikova, I. G., Salk, H. M., Kennedy, R. B., Haralambieva, I. H., Zimmermann, M. T., Grill, D. E., Oberg, A. L., & Poland, G. A. (2016) · Genes and Immunity · doi:10.1038/gene.2016.34 · Cited by 21 · see citing works

Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations

Zimmermann, M. T., Kennedy, R. B., Grill, D. E., Oberg, A. L., Goergen, K. M., Ovsyannikova, I. G., Haralambieva, I. H., & Poland, G. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00445 · Cited by 21 · see citing works

Estimating and Testing Vaccine Sieve Effects Using Machine Learning

Benkeser, D. C., Gilbert, P. B., & Carone, M. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2018.1529594 · Cited by 21 · see citing works

TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines

Martinón‐Torres, F., Bosch, X. F., Rappuoli, R., Ladhani, S. N., Redondo, E., Vesikari, T., García‐Sastre, A., Calle, I. R., Rial, J. G., Salas, A., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1609823 · Cited by 21 · see citing works

Genetic Variation in IL18R1 and IL18 Genes and Inteferon γ ELISPOT Response to Smallpox Vaccination: An Unexpected Relationship

Ovsyannikova, I. G., Haralambieva, I. H., Kennedy, R. B., O’Byrne, M. M., Pankratz, V. S., & Poland, G. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit341 · Cited by 20 · see citing works

Synergism of Tapasin And Human Leukocyte Antigens in Resolving Hepatitis C Virus Infection

Ashraf, S., Nitschke, K., Warshow, U. M., Brooks, C., Kim, A. Y., Lauer, G. M., Hydes, T., Cramp, M., Alexander, G., Little, A., et al. (2013) · Hepatology · doi:10.1002/hep.26415 · Cited by 19 · see citing works

Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells

Sen, N., & Arvin, A. M. (2016) · Journal of Virology · doi:10.1128/jvi.03375-14 · Cited by 19 · see citing works

Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR

Nishiyama, S., Slack, O. A. L., Lokugamage, N., Hill, T. E., Juelich, T. L., Zhang, L., Smith, J. K., Perez, D., Gong, B., Freiberg, A. N., et al. (2016) · Virulence · doi:10.1080/21505594.2016.1195528 · Cited by 19 · see citing works

Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines

Alsarraf, H. M. A. B., Dedic, E., Bjerrum, M. J., Østergaard, O., Kristensen, M. P., Petersen, J. W., & Jørgensen, R. (2017) · Virulence · doi:10.1080/21505594.2017.1321726 · Cited by 19 · see citing works

The Human Vaccines Project: Towards a comprehensive understanding of the human immune response to immunization

Wooden, S. L., & Koff, W. C. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1476813 · Cited by 19 · see citing works

Proteomic Analysis of Membrane Blebs of Brucella abortus 2308 and RB51 and Their Evaluation as an Acellular Vaccine

Araiza-Villanueva, M. G., Ávila-Calderón, E. D., Flores‐Romo, L., Calderón‐Amador, J., Sriranganathan, N., Alqublan, H., Witonsky, S. G., Aguilera‐Arreola, M. G., Ruiz-Palma, M. D. S., Ruíz, E. A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02714 · Cited by 19 · see citing works

Vaccidents and adversomics

Poland, G. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.032 · Cited by 18 · see citing works

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

Rudenko, L. G., Isakova-Sivak, I. N., & Rekstin, A. R. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2014.864564 · Cited by 18 · see citing works

Pharmaceutical Approval Update.

Fellner, C. (2015) · PubMed · Cited by 18 · see citing works

Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial

Chu, K., Hu, J., Meng, F., Li, J., Luo, L., Xu, J., Yuan, Z., Li, Z., WanGeng, C., Jiao, L., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1175261 · Cited by 17 · see citing works

Localized Hypermutation is the Major Driver of Meningococcal Genetic Variability during Persistent Asymptomatic Carriage

Green, L. R., Al-Rubaiawi, A. A. A., Al-Maeni, M. A. R., Harrison, O. B., Blades, M., Oldfield, N. J., Turner, D. P. J., Maiden, M. C. J., & Bayliss, C. D. (2020) · mBio · doi:10.1128/mbio.03068-19 · Cited by 17 · see citing works

Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection

Tang, X., Zhang, H., Song, Y., Zhou, D., & Wang, J. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.25 · Cited by 16 · see citing works

There is no hiding if you Seq: recent breakthroughs in Pseudomonas aeruginosa research revealed by genomic and transcriptomic next-generation sequencing

Valli, R. X. E., Lyng, M., & Kirkpatrick, C. L. (2020) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001135 · Cited by 16 · see citing works

Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates

Schulz, C., & Hammerschmidt, S. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.824708 · Cited by 15 · see citing works

Identification of novel Tapasin polymorphisms and linkage disequilibrium to MHC class I alleles

Williams, A. P., Bevan, S., Bunce, M., Houlston, R. S., Welsh, K. I., & Elliott, T. J. (2000) · Immunogenetics · doi:10.1007/s002510000244 · Cited by 14 · see citing works

Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells

Scarno, G., Pietropaolo, G., Censo, C. D., Gadina, M., Santoni, A., & Sciumè, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02456 · Cited by 14 · see citing works

Common Cold, Uncommon Variation

Poland, G. A., & Barry, M. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmcibr0902053 · Cited by 13 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

mRNA vaccines in disease prevention and treatment

Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 253 · see citing works

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy

Han, X., Alu, A., Liu, H., Shi, Y., Wei, X., Cai, L., & Wei, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.011 · Cited by 159 · see citing works

Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines

Lee, J., Woodruff, M. C., Kim, E. H., & Nam, J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00999-x · Cited by 137 · see citing works

Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19

Vahedifard, F., & Chakravarthy, K. V. (2021) · Emergent Materials · doi:10.1007/s42247-021-00168-8 · Cited by 129 · see citing works

Viral hepatitis update: Progress and perspectives

Pisano, M. B., Giadans, C. G., Flichman, D. M., Re, V. E., Preciado, M. V., & Valva, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4018 · Cited by 104 · see citing works

Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review

Asadi, K., & Gholami, A. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.005 · Cited by 98 · see citing works

mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases

Le, T., Sun, C., Chang, J., Zhang, G., & Yin, X. (2022) · Viruses · doi:10.3390/v14020401 · Cited by 93 · see citing works

Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies

Deshmukh, R., Sethi, P., Singh, B., Shiekmydeen, J., Salave, S., Patel, R. J., Ali, N., Rashid, S., Elossaily, G. M., & Kumar, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081076 · Cited by 59 · see citing works

Vaccinomics: a future avenue for vaccine development against emerging pathogens

de la Fuente, J., & Contreras, M. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1987222 · Cited by 48 · see citing works

Vaccines and Antivirals: Grand Challenges and Great Opportunities

Andreï, G. (2021) · Frontiers in Virology · doi:10.3389/fviro.2021.666548 · Cited by 45 · see citing works

Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern

Saha, A., Roy, S. G., Dwivedi, R., Tripathi, P., Kumar, K., Nambiar, S. M., & Pathak, R. (2025) · Vaccines · doi:10.3390/vaccines13040424 · Cited by 44 · see citing works

Prophylactic and therapeutic vaccine development: advancements and challenges

Weerarathna, I. N., Doelakeh, E. S., Kiwanuka, L., Kumar, P., & Arora, S. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00222-x · Cited by 43 · see citing works

Systems immunology analysis of human immune organoids identifies host-specific correlates of protection to different influenza vaccines

Wagoner, Z. W., Yates, T. B., Hernandez‐Davies, J. E., Sureshchandra, S., Joloya, E. M., Jain, A., de Assis, R., Kastenschmidt, J. M., Sorn, A. M., Mitul, M. T., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.01.014 · Cited by 30 · see citing works

A Structural View at Vaccine Development against M. tuberculosis

Romanò, M., Squeglia, F., Kramarska, E., Barra, G., Choi, H., Kim, H., Ruggiero, A., & Berisio, R. (2023) · Cells · doi:10.3390/cells12020317 · Cited by 27 · see citing works

Nonclinical safety evaluation of a novel ionizable lipid for mRNA delivery

Broudic, K., Amberg, A., Schaefer, M. K., Spirkl, H.-P., Bernard, M., & Désert, P. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116143 · Cited by 25 · see citing works

Principles in Immunology for the Design and Development of Vaccines

Meyer, C. U., & Zepp, F. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_2 · Cited by 23 · see citing works

Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems

Li, J., Zhang, Y., Yang, Y., & Sun, T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00276 · Cited by 23 · see citing works

Advances in Nanotechnology Research in Food Production, Nutrition, and Health

Han, K., Yang, H., Fan, D., & Deng, J. (2025) · Nutrients · doi:10.3390/nu17152443 · Cited by 19 · see citing works

Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines

Gu, J., Xu, Z., Liu, Q., Tang, S., Zhang, W., Xie, S., Chen, X., Chen, J., Yong, K., Yang, C., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302409 · Cited by 19 · see citing works

Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding

Kumar, P., Kumar, P., Shrivastava, A., Dar, M. A., Lokhande, K. B., Singh, N., Singh, A., Ravichandiran, V., & Mandal, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127567 · Cited by 17 · see citing works

Nano-Carriers of COVID-19 Vaccines: The Main Pillars of Efficacy

Constantin, C., Pisani, A., Bardi, G., & Neagu, M. T. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0250 · Cited by 15 · see citing works

Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination

Rawat, B. S., Kumar, D., Soni, V., & Rosenn, E. H. (2022) · Vaccines · doi:10.3390/vaccines10122127 · Cited by 15 · see citing works

Quantum vaccinomics platforms to advance in vaccinology

de la Fuente, J., & Contreras, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172734 · Cited by 14 · see citing works

How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika

Abernathy, M., Dam, K. A., Esswein, S., Jette, C. A., & Bjorkman, P. (2021) · Viruses · doi:10.3390/v13102106 · Cited by 11 · see citing works

Emerging technologies and innovative approaches to combat antimicrobial resistance: A narrative review of next-generation therapeutic strategies

Lucero‐Prisno, D. E., Okesanya, O. J., Agboola, A. O., Adebayo, U. O., Adigun, O. A., Ahmed, M. M., Olaleke, N. O., Oso, T. A., Tan, M. I. R. S., Ogaya, J. B., et al. (2025) · Next Bioengineering · doi:10.1016/j.nxbio.2025.100003 · Cited by 16 · see citing works

Advancements in viral vaccine development: from traditional to modern approaches

Kumar, A., Ahmad, F., Sah, B. K., Aljabali, A. A. A., Mishra, Y., & Mishra, V. K. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003203 · Cited by 13 · see citing works

Graph-theoretical formulation of the generalized epitope-based vaccine design problem

Dorigatti, E., & Schubert, B. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008237 · Cited by 13 · see citing works

Constructing Physiological Defense Systems against Infectious Disease with Metal–Organic Frameworks: A Review

Mishra, N., Quon, A. S., Nguyen, A., Papazyan, E. K., Hao, Y., & Liu, Y. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00391 · Cited by 13 · see citing works

Virus-like particles in poultry disease: an approach to effective and safe vaccination

Raji, A. A., Dastjerdi, P. Z., & Omar, A. R. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1405605 · Cited by 12 · see citing works

Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects

Wei, Z., Zhang, S., Wang, X., Xue, Y., Dang, S., & Zhai, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1524317 · Cited by 13 · see citing works

RNA Vaccines: Yeast as a Novel Antigen Vehicle

Silva, A. J. D., de Sousa, M. M. G., de Macêdo, L. S., Franca-Neto, P. L., de Moura, I. A., Espinoza, B. C. F., Invenção, M. D. C. V., de Pinho, S. S., da Gama, M. A. T. M., & de Freitas, A. C. (2023) · Vaccines · doi:10.3390/vaccines11081334 · Cited by 11 · see citing works

The Nature of the Problem of Immunity and its SolutionPreprint

Ola, P. (2022) · doi:10.31219/osf.io/zmqsg · Cited by 11 · see citing works

Vaccinomics: A scoping review

Dudley, M. Z., Gerber, J. E., Ni, H. B., Blunt, M., Holroyd, T. A., Carleton, B., Poland, G. A., & Salmon, D. A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.009 · Cited by 10 · see citing works

Recent Global Trends in Vaccinology, Advances and Challenges

Aqib, A. I., Anjum, A. A., Islam, M. A., Murtaza, A., & Rehman, A. U. (2023) · Vaccines · doi:10.3390/vaccines11030520 · Cited by 10 · see citing works

Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

Nicoli, F., Mantelli, B., Gallerani, E., Telatin, V., Squarzon, L., Masiero, S., Gavioli, R., Palù, G., Barzon, L., & Caputo, A. (2022) · npj Vaccines · doi:10.1038/s41541-022-00458-0 · Cited by 10 · see citing works

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10 · see citing works

Methods integrating innate and adaptive immune responses in human in vitro immunization assays

Bowley, T. Y., Lenz, K. D., Shanker, A., & Kubicek-Sutherland, J. Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584852 · Cited by 8 · see citing works

Pharmacogenomics and Vaccine Development

Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2288 · Cited by 8 · see citing works

Exploring the genetic diversity of Edwardsiella ictaluri in Vietnamese striped catfish (Pangasianodon hypophthalmus) farms over a 20-year period

Payne, C. J., Grace, K., Phuong, V. H., Phước, N. N., Dung, T. T., Phước, L. H., & Crumlish, M. (2023) · Frontiers in Marine Science · doi:10.3389/fmars.2023.1270968 · Cited by 7 · see citing works

Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System

Tatarūnas, V., Čiapienė, I., & Giedraitienė, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020292 · Cited by 7 · see citing works

Biodegradable nanoplatforms for antigen delivery: part I – state of the art review of polymeric nanoparticles for cancer immunotherapy

Vega, E., Burgos, J. M., Souto, E. B., García, M. L., Pujol, M., & Sánchez‐López, E. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2400293 · Cited by 6 · see citing works

Advancing novel veterinary vaccines: From comprehensive antigen and adjuvant design to preparation process optimization

Zhang, M., Wang, C., Pan, J., Cui, H., & Zhao, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113784 · Cited by 6 · see citing works

Vaccine Development Through Reverse Vaccinology Using Artificial Intelligence and Machine Learning Approach

Bhakta, S., Choudhury, S., Paul, J., & Bhattacharya, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85844-1.00006-4 · Cited by 6 · see citing works

Early B cell transcriptomic markers of measles-specific humoral immunity following a 3rd dose of MMR vaccine

Haralambieva, I. H., Chen, J., Quach, H. Q., Ratishvili, T., Warner, N. D., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1358477 · Cited by 6 · see citing works

Movement disorders, cerebral palsy and vaccination

Libá, Z., Kraus, J., Necas, T., Necas, J., Klugar, M., & Kršek, P. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.12.006 · Cited by 5 · see citing works

3D printing technologies forin vitrovaccine testing platforms and vaccine delivery systems against infectious diseases

Choi, J. Y., Mahadik, B. P., & Fisher, J. P. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200105 · Cited by 5 · see citing works

Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques

Sugandhi, V. V., Gadhave, D. G., Khot, S. V., Jadhav, K., Patel, D., Thapa, R., Verma, R. K., Rojekar, S. V., Patil, N. G., Jha, S. K., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106960 · Cited by 4 · see citing works

Applied immunoinformatics in modern vaccine design: a comprehensive review of available computational tools

Miles, S., Mourglia‐Ettlin, G., & Chabalgoity, J. A. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128392 · Cited by 4 · see citing works

A Commentary on Multi-omics Data Integration in Systems Vaccinology

Shannon, C. P., Lee, A. H., Tebbutt, S. J., & Singh, A. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168522 · Cited by 4 · see citing works

Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease

Aderinto, N., Abraham, I. C., Olatunji, G. D., Kokori, E., Ashinze, P. T., Babawale, E. A., Alabi, B. O., Opeyemi, O. D., Babalola, A. E., Ayoola, O. I., et al. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-025-00827-9 · Cited by 4 · see citing works

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented

Ryan, M., & Montgomery, J. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00091-1 · Cited by 4 · see citing works

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Mosa, A. I., Campo, D. S., Khudyakov, Y. E., Haidar, M. A., Gehring, A. J., Zahoor, M. A., Ball, J. K., Urbanowicz, R. A., & Feld, J. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220294120 · Cited by 4 · see citing works

Application of gold nanoparticles in vaccine development

Farfán-Castro, S., García-Soto, M. J., Aguilar‐Aguilar, A., González‐Ortega, O., & Rosales‐Mendoza, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19061-2.00003-1 · Cited by 4 · see citing works

Immunoinformatics-guided vaccine design: A review with case study on Marburg virus

Rao, D. F., Patel, S., & Pandya, H. A. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152572 · Cited by 3 · see citing works

Prevention as a Pillar of Communicable Disease Control: Strategies for Equity, Surveillance, and One Health Integration

Genovese, G., Rizzo, C. E., Bartucciotto, L., Calderone, S. M., Loddo, F., Leonforte, F., Mistretta, A., Squeri, R., & Genovese, C. (2026) · Epidemiologia · doi:10.3390/epidemiologia7010019 · Cited by 3 · see citing works

Ex vivo observation of Pythium insidiosum -antigen treated neutrophils on three Pythium insidiosum strains isolated from vascular pythiosis patients

Medhasi, S., Sriwarom, A., Permpalung, N., Torvorapanit, P., Plongla, R., Chindamporn, A., & Worasilchai, N. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2304372 · Cited by 3 · see citing works

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine

Domnich, A., Orsi, A., Lai, P. L., Massaro, E., Trombetta, C.-S., Pastorino, J., Roihl, C., Pianta, M., Icardi, G., & Panatto, D. (2025) · Medicina · doi:10.3390/medicina61010067 · Cited by 3 · see citing works

The mental health implication of mpox: Enhancing care with genetic insights

Ejiohuo, O. (2025) · Journal of Public Health in Africa · doi:10.4102/jphia.v16i1.786 · Cited by 3 · see citing works

Major locus on ECA18 influences effectiveness of GonaCon vaccine in feral horses

Thompson, M. A., McCann, B. E., Simmons, R. B., & Rhen, T. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103779 · Cited by 3 · see citing works

Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection

Gbédandé, K., Ibitokou, S. A., Endrino, M. J., Yap, G. S., Brown, M. G., & Stephens, R. (2024) · iScience · doi:10.1016/j.isci.2024.111468 · Cited by 3 · see citing works

A Preliminary Investigation on a Commercial Ovine Pasteurellosis Vaccine Using Clinical and Pathological Endpoints

Asfaw, M., Senbit, M., Yesuf, M., Fenta, M. D., Birhan, G., Abat, A. S., & Ibrahim, S. M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s365745 · Cited by 3 · see citing works

Genetic origins of microbial virulence

Chatterjee, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31554-1.00010-8 · Cited by 3 · see citing works

Mandatory Childhood Vaccinations in Poland—The Art of Preventing the PreventablePreprint

Kamińska, A., & Plata‐Nazar, K. (2023) · Preprints.org · doi:10.20944/preprints202311.0261.v1 · Cited by 3 · see citing works

Machine learning (ML) and deep learning (DL) in vaccine target selection, design, development and characterization

Bhattacharya, M., Chatterjee, S., Das, A., Lee, S., & Chakraborty, C. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.128051 · Cited by 2 · see citing works

Engineering cationic nanovaccines to enable precision immunotherapy in infectious diseases and cancer

Lee, S., Kim, J., Kim, B., Kim, B.-S., Shin, J., Choi, J., Kim, M., Seo, Y. H., Kim, B. H., Lim, K. S., et al. (2026) · Discover Applied Sciences · doi:10.1007/s42452-025-08209-1 · Cited by 2 · see citing works

Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions

Uti, D. E., Alum, E. U., & Ugwu, O. P.-C. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101166 · Cited by 2 · see citing works

Enhancing mRNA therapeutics production: A platform technology approach through IVT modeling insights

Ahmed, M., Nair, A., Middleton, J., Loveday, K. A., Brown, S., Kis, Z., & Cordiner, J. (2026) · Results in Engineering · doi:10.1016/j.rineng.2026.110088 · Cited by 2 · see citing works

A Narrative Review on the Promising Potential of Graphene in Vaccine Design: Evaluating the Benefits and Drawbacks of Carbon Nanoplates in Nanovaccine Production

Zare‐Zardini, H., Saberian, E., Jenča, A., Jenča, A., Petrášová, A., & Jenčová, J. (2024) · Vaccines · doi:10.3390/vaccines12060660 · Cited by 2 · see citing works

Towards precision epitopes based vaccine against Enterococcus faecalis by integrating vaccinomics, reverse vaccinology and biophysics approaches

Ullah, A., Azam, S., Ahmad, S., Khan, I., Alammari, D. M., Abassi, S. W., Wei, D., Alshabrmi, F. M., Aljasir, M. A., & Alatawi, E. A. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102082 · Cited by 2 · see citing works

Why not the ‘marker’ or DIVA vaccines for the control of emerging infectious diseases of humans?

Singh, A. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.01.069 · Cited by 2 · see citing works

AI-Assisted Vaccine Design and Development in Immunological Disorders

Tavare, N., Singh, R., & Barage, S. H. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-9725-1.ch006 · Cited by 1 · see citing works

Harnessing immunoinformatics for the rational design of mRNA vaccines against the emerging Junin virus

Oladipo, E. K., Irewolede, B. A., Aderibigbe, K. A., Hammed, O. S., Jegede, A. J., Opeyemi, O. H., Adaeze, C. J., Adedotun, O. J., Adebola, A. M., Dorcas, A. O., et al. (2026) · In Silico Pharmacology · doi:10.1007/s40203-026-00587-7 · Cited by 1 · see citing works

mRNA vaccines for viral diseases: mechanism, advances, and future perspective

Chakraborty, B., & Singh, T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11856-1 · Cited by 1 · see citing works

Role of nanotechnology in diagnosis and disease control with a focus on COVID-19 and future perspectives

Rashid, M. H. A., Saha, D., & Mandal, S. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90750-7.00004-1 · Cited by 1 · see citing works

Individual expression and processing of hepatitis C virus E1/E2 epitopes-based DNA vaccine candidate in healthy humans’ peripheral blood mononuclear cells

Nadeem, R., Maghraby, A. S., Abd‐Elshafy, D. N., Barakat, A., & Bahgat, M. M. (2023) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2023.12.1.47 · Cited by 1 · see citing works

Personalized vaccinology

Garse, S., Dokhale, S., Bhandari, G. K., Kapadiya, V., Prabhakar, K., & Devarajan, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15526-0.00002-0 · Cited by 1 · see citing works

Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice

Shi, Z., Moon, S.-S., Zou, J., Wang, Y., Bhatnagar, N., Ngo, V. L., Wang, X., Wang, H., Bessey, T. K., Hull, J. J., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01126-9 · Cited by 1 · see citing works

Brief Introduction of Measles Virus and Its Therapeutic Strategies

Nascimento, I. J. D. S., Santos-Júnior, P. F. D. S., & da Silva‐Júnior, E. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71165-8_23 · Cited by 1 · see citing works

The Art of Oncoimmunovaccinomics

Ikrar, T., & Anurogo, D. (2021) · World Journal of Vaccines · doi:10.4236/wjv.2021.114007 · Cited by 1 · see citing works

Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines

Voit, K., Timmermann, C., Orzechowski, M., & Steger, F. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.995683 · Cited by 1 · see citing works

The Nature of the Problem of Immunity and its SolutionPreprint

Ola, P. (2022) · doi:10.22541/au.165926450.03622785/v1 · Cited by 1 · see citing works

Nanotechnology and Vaccine Development

Jetha, K. L., Bharadia, P. D., & Patel, M. P. (2024) · doi:10.1002/9781394175482.ch3 · Cited by 1 · see citing works

Charting targeted courses for vaccination

(2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01366-z · Cited by 1 · see citing works

Develop a durable, memory-driven, CspZ-targeting Lyme disease vaccine by rationale adjuvant selectionPreprint

McCarty, M., Hernández, S. A., Malfetano, J., Leao, A. C., Villar, M. J., Yang, X., Chen, Y.-L., Lee, J., Liu, Z., Strych, U., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.08.698480 · Cited by 1 · see citing works

Expected and Unexpected Effects of Vaccination

Martinón‐Torres, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-77173-7_1

Covid-19: Estratégias gerais nas instituições de ensino

Troca, R. S., Mundim, F. G. L., & Salomé, G. M. (2022) · doi:10.22533/at.ed.938222511

Персоніфікований підхід у вакцинопрофілактиці в умовах воєнного та повоєнного часу

Смілянська, М. В., Волянський, А., Мороз, М., & Звєрєва, Н. (2024) · InterConf · doi:10.51582/interconf.19-20.02.2024.045

Anais Eletrônicos do XX Congresso de Iniciação Científica da Univás - 2023

Mendonça, A. R. D. A., Lopes, A. N., Silva, A. M. F., Salles, A. C., Carlos, B. L., Pereira, D. H., de Castro, F. E., dos Santos, M. A., Nogueira, J. P. D. F., Neto, J. D. D. S., et al. (2023) · doi:10.54665/9786585924016

Systems Biology in the Field of Vaccine Development

Okay, S. (2024) · RNA technologies · doi:10.1007/978-3-031-62178-9_12

Revolutionizing Healthcare: Unleashing the Potential of Immunotherapies to Strengthen the Body’s Immune Defense Against Antibiotic-Resistant Pathogen

Patil, A., Nagulwar, V. P., Yadav, S. K., Tabassum, F., & Gautam, S. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_7

Immunological and Immunogenetic Aspects of Vaccination against Measles

Фомичев, В. И., Михайловна, Х. С., & Vilnits, A. A. (2025) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2025-24-3-114-122

The Future of Vaccine IP Right

Raghuwanshi, V., Jain, S. K., & Soni, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274769125010010

The State of Public Opinion on the Immunoprophylaxis of Infectious Diseases

Solov’yov, D. V., Glinenko, V. M., Sapozhnikova, E. V., Smirnova, O. A., Korabelnikova, M. I., Васильевич, Д. Д., Vlasenko, N. V., Panasyuk, Y. V., Nikitina, G. Y., & Кузин, С. Н. (2025) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2025-24-4-42-51

Effect of Particle Synthesis Method on Protein Release and Stability

Sanchez, D., & Narasimhan, B. (2025) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35685

Vaccine Clinical Trials

Madhavrao, C., Bai, K. M., Chenchula, S., & SHARMA, S. K. (2025) · Introduction to Basics of Pharmacology and Toxicology · doi:10.1007/978-981-95-1920-0_19

An integrated immunoinformatic approach to design a novel multiepitope chimeric vaccine against Mycoplasma phocimorsus as a causal agent of bloodstream infections

Yu, R., Hasan, A., Ibrahim, M. K., Alonazi, W. B., & Li, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1719398

Designing a multi-epitope vaccine to harness computational immunology for next-generation tuberculosis control

Olatunde, S. K., Oyedele, A. O., Alli, Y. A., Oladipo, E. K., Ajisafe, H. M., & Abiodun, C. S. (2026) · Next research. · doi:10.1016/j.nexres.2026.101398

Undergraduate interest in vaccines: insights from the “Adopt a Bacterium” active learning methodology in the post-COVID-19 Period

Baroni, L. N., Picinin, N. G., Nastaro, C. D., Marana, S. R., Moreno, A. C. R., & Ferreira, R. D. C. C. (2026) · Journal of Biological Education · doi:10.1080/00219266.2026.2628790

A REVIEW: CHALLENGES IN VACCINE DEVELOPMENTPreprint

Sonalkar, M. Y. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13682996

The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development

Kennedy, R. B., & Poland, G. A. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0012 · Cited by 48 · see citing works

Publics and Vaccinomics: Beyond Public Understanding of Science

Einsiedel, E. F. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0139 · Cited by 8 · see citing works

Vaccinomics and a New Paradigm for the Development of Preventive Vaccines Against Viral Infections

Poland, G. A., Ovsyannikova, I. G., Kennedy, R. B., Haralambieva, I. H., & Jacobson, R. M. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0032 · Cited by 95 · see citing works

Designing the Next Generation of Vaccines for Global Public Health

Bagnoli, F., Baudner, B. C., Mishra, R. P. N., Bartolini, E., Fiaschi, L., Mariotti, P., Nardi‐Dei, V., Boucher, P., & Rappuoli, R. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0127 · Cited by 77 · see citing works